Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Glory Star Enters into Strategic Cooperation with Haier Group to Develop New "Home Life Service" Channel 2021-06-08 19:30
ChipMOS to Present at Investor Conference Hosted by the Taiwan Stock Exchange and MasterLink Securities 2021-06-08 18:00
"Memoria" Co-produced by iQIYI and Xstream Pictures Joins Cannes International Film Festival 2021 Competition Lineup 2021-06-08 17:18
Zoomlion Launches Operations of New Factory in Europe Further Driving Localized Manufacturing 2021-06-08 17:02
Yum China Commits to the Science Based Targets Initiative to Reinforce its Climate Action Efforts 2021-06-08 16:30
GWM's Globalization Strategy is accelerated on 2nd Anniversary of Tula Factory in Russia 2021-06-08 16:23
Zhangmen Education Inc. Announces Pricing of Initial Public Offering 2021-06-08 16:20
AVerMedia launches Live Streamer NEXUS and MIC 330, a content creator control center/6-track audio mixer and a dynamic XLR microphone 2021-06-08 16:00
Momo Announces Unaudited Financial Results for the First Quarter of 2021 2021-06-08 15:45
Inspiring Women's Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System 2021-06-08 15:37
iHuman Inc. Announces First Quarter 2021 Unaudited Financial Results 2021-06-08 13:47
Ying Hai Announces Possible Acquisition of a Zhuhai Travel Company 2021-06-08 11:35
A Snapshot of SID Display Week 2021: BOE leads the way in display industry, bringing momentum to "China's moment" 2021-06-08 11:17
Pearl Abyss Releases BUGATTI Collaboration for Black Desert 2021-06-08 10:47
Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress 2021-06-08 08:00
Live from ASCO 2021 | Ascentage Pharma Delivers Oral Presentation Featuring Updated Data Demonstrating Promising Efficacy and Safety of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Patients with Relapsed or Refractory CLL/SLL 2021-06-08 07:30
Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs 2021-06-08 07:21
TIAN RUIXIANG Holdings Ltd Announces Initial Closing of Follow-on Public Offering 2021-06-08 04:30
Senmiao Technology Announces Over 2.1 Million Completed Rides on its Ride-Hailing Platform in May 2021 2021-06-07 21:00
ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in the United States and Puerto Rico 2021-06-07 21:00
1 1504 1505 1506 1507 1508 3741